Endoparasite control agent
US-2016367532-A1 · Dec 22, 2016 · US
US10017490B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10017490-B2 |
| Application number | US-201615267139-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 15, 2016 |
| Priority date | Aug 30, 2012 |
| Publication date | Jul 10, 2018 |
| Grant date | Jul 10, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An object of the present invention is to provide a novel endoparasite control agent as a parasiticide, an antiprotozoal or the like. Provided is an endoparasite control agent comprising a carboxamide derivative represented by the general formula (I): or a salt thereof as an active ingredient.
Opening claim text (preview).
The invention claimed is: 1. A method for controlling endoparasites, comprising orally or parenterally administering an effective amount of an endoparasite control composition comprising a compound of the general formula (I): wherein each X may be the same or different, and represents a halogen atom; a cyano group; a nitro group; an amino group; a (C 1 -C 6 ) alkyl group; a halo (C 1 -C 6 ) alkyl group; a (C 1 -C 6 ) alkoxy group; a halo (C 1 -C 6 ) alkoxy group; a (C 1 -C 6 ) alkylthio group; a halo (C 1 -C 6 ) alkylthio group; a (C 1 -C 6 ) alkylsulfinyl group; a halo (C 1 -C 6 ) alkylsulfinyl group; a (C 1 -C 6 ) alkylsulfonyl group; or a halo (C 1 -C 6 ) alkylsulfonyl group, m represents an integer of to 1 or 2, A is a moiety represented by one of the following A1 to A7: E represents a hydrogen atom; a (C 1 -C 6 ) alkyl group; a (C 3 -C 6 ) cycloalkyl group; a (C 1 -C 6 ) alkoxy (C 1 -C 6 ) alkyl group; a (C 1 -C 6 ) alkylcarbonyl group; or a (C 1 -C 6 ) alkoxycarbonyl group, and B represents a moiety represented by B1: wherein each Y may be the same or different, and represents a halogen atom; a heterocycloxy group; or a substituted heterocycloxy group having one or more substituents selected from a halogen atom; and a halo (C 1 -C 6 ) alkyl group, n represents an integer of 0 to 5, and the numbers on each ring represent positions where the ring can be substituted by Y and the free bond extending from each ring is a bond between A and B, or a salt thereof as an active ingredient to a non-human mammal or a bird, wherein the endoparasite belongs to the scope of order Strongylida or Ascaridida. 2. The method according to claim 1 , wherein the endoparasite control composition is administered orally or parenterally to a non-human mammal. 3. The method according to claim 2 , wherein the non-human mammal is a domestic animal. 4. The method according to claim 1 , wherein A is A1, A2 or A3. 5. The method according to claim 1 , wherein the compound of the general formula (I) is a compound of the formula:
Anthelmintics · CPC title
Antiparasitic agents · CPC title
Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis · CPC title
One oxygen or sulfur atom · CPC title
having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.